Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $625 to $650.
Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $625 to $650.